Background Image
Previous Page  99 / 99
Information
Show Menu
Previous Page 99 / 99
Page Background

D

USSE

LMS

ET

AL

.

186

r

Ev

a

SSoC

m

ED

B

raS

2014; 60(2):181-186

sitivos, é um desaio clínico e laboratorial, uma vez que

tais resultados podem levar a decisões clínicas erradas,

como a prescrição de anticoagulante oral, levando ao

risco de hemorragia. Além disso, os clínicos muitas ve-

zes não estão familiarizados com esses testes e têm dii-

culdade em interpretá-los, sendo necessária a interação

da clínica e dos proissionais do laboratório para asse-

gurar sua correta interpretação.

Unitermos:

síndrome do anticorpo antifosfolípide; sín-

drome antifosfolipídica; diagnóstico clínico; testes labo-

ratoriais; fase pré-analítica.

R

EFERENCES

1. Hughes GRHN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol

1986; 13(3):486-9.

2. Backer Jr. WF, Bick RL. The clinical spectrum of antiphospholipid syndrome.

Hematol Oncol Clin North Am 2008; 22(1):33-52.

3. De Groot PG. Mechanisms of anti-phospholipid antibody formation and

action. Thromb Res 2011; 127(Suppl 3):S40-S2.

4. Aird WC. Spatial and temporal dynamics of the endothelium. J Thromb

Haemost 2005; 3(7):1392-406.

5. Peluso SAA, De Rosa A, Roca A, Maddaluno G, Brescia Morra V, De Michele

G. Antiphospholipid-related chorea. Front Neurol 2012; 3:1-7.

6. Hadi HA, Treadwell EL. Lupus anticoagulant and anticardiolipin antibodies

in pregnancy: a review. Immunochemistry and clinical implications. Obstet

Ginecol Surv 1990; 45(11):780-5.

7. Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implications of

autoimmunity and pregnancy. J Autoimmun 2010; 34(3):J287-J99.

8. Greaves M. Antiphospholipid syndrome: unusual clinical presentations.

Thromb Res 2011; 127(Suppl 3):S47-S50.

9. Borba EF, Bonfá E, Asherson. RA. Catastrophic antiphospholipid syndrome

(Asherson’s Syndrome) revealed. J Bras Reumatol 2005; 5(2):374-81.

10. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al.

International consensus statement on an update of the classiication criteria

for deinite antiphospholipid syndrome (APS). J Thromb Haemost 2006;

4(2):295-306.

11. Devreese K, Hoylaerts MF. Challenges in the diagnosis of the antiphospholipid

syndrome. Clin Chem 2010; 56(6):930-40.

12. Neville CRJ, Kassis J, Chang ER, Joseph L, Le Comte M, Fortin PR.

Thromboembolic risk in patients with high titre anticardiolipin and multiple

antiphospholipid antibodies. Thromb Haemost 2003; 90(1):108-15.

13. Rand JH WL. Dos and don’ts in diagnosing antiphospholipid syndrome.

Hematology Am Soc Hematol Educ Program 2012; 455-9.

14. Pengo VBA, Gresele P, Marongiu F, Erba N, Veschi F, Ghirarduzzi A et al.

Survey of lupus anticoagulant diagnosis by central evaluation of positive

plasma samples. J Thromb Haemost 2007; 5(5):925-30.

15. Miyakis SLM, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH et al.

International consensus statement on an update of the classiication criteria

for deinite antiphospholipid syndrome (APS). J Thromb Haemost 2006;

4(2):295-306.

16. Sletnes KE, Gravem K, Wisloff F. Preparation of plasma for the detection

of lupus anticoagulants and antiphospholipid antibodies. Thromb Res

1992; 66(1):43-53.

17. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies

- isotype distribution and phospholipid speciicity. Ann Rheumat Dis 1987;

46(1):1-6.

18. Suh-Lailam BB, Cromar A, Davis KW, Tebo AE. APhL antibody ELISA as

an alternative to anticardiolipin test for the diagnosis of antiphospholipid

syndrome. International J Clin Exp Pathol 2012; 5(3):210-5.

19. Levine JS BD, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;

346(10):752-63.

20. Cecatti JG AM, Tintori EM, Yela DA, Queiroz MLS. Anticorpos

anticardiolipina entre gestantes com óbito fetal. RBGO 2000; 22(2):101-6.

21. Pengo V. APS - controversies in diagnosis and management, critical

overview of current guidelines. Thromb Res 2011; 127(Suppl 3):S51-S2.

22. Pengo V. A contribution to the debate on the laboratory criteria that

define the antiphospholipid syndrome. J Thromb Haemost 2008;

6(6):1048-9.

23. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody

assays - A cautious approach is suggested by high variation and limited

consensus in multilaboratory testing. Am J Clin Pathol 2002; 118(4):548-57.

24. Asherson RA, Khamashta MA, Ordiros J, Derksen RH, Machin SJ,

Barquinero J et al. The primary antiphospholipid syndrome - major

clinical and serological features. Medicine 1989; 68(6):366-74.

25. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M et al. Update

of the guidelines for lupus anticoagulant detection. Subcommittee on

Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and

Standardisation Committee of the International Society on Thrombosis

and Haemostasis. J Thromb Haemost 2009; 7(10):1737-40.

26. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russel viper venom

for the diagnosis of lupus anticoagulants. Blood 1986; 68(4):869--74.

SCIELO BOOK.indb 186

4/22/14 4:35 PM